» Articles » PMID: 21302010

Prediction-corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-effects Models

Overview
Journal AAPS J
Specialty Pharmacology
Date 2011 Feb 9
PMID 21302010
Citations 732
Authors
Affiliations
Soon will be listed here.
Abstract

Informative diagnostic tools are vital to the development of useful mixed-effects models. The Visual Predictive Check (VPC) is a popular tool for evaluating the performance of population PK and PKPD models. Ideally, a VPC will diagnose both the fixed and random effects in a mixed-effects model. In many cases, this can be done by comparing different percentiles of the observed data to percentiles of simulated data, generally grouped together within bins of an independent variable. However, the diagnostic value of a VPC can be hampered by binning across a large variability in dose and/or influential covariates. VPCs can also be misleading if applied to data following adaptive designs such as dose adjustments. The prediction-corrected VPC (pcVPC) offers a solution to these problems while retaining the visual interpretation of the traditional VPC. In a pcVPC, the variability coming from binning across independent variables is removed by normalizing the observed and simulated dependent variable based on the typical population prediction for the median independent variable in the bin. The principal benefit with the pcVPC has been explored by application to both simulated and real examples of PK and PKPD models. The investigated examples demonstrate that pcVPCs have an enhanced ability to diagnose model misspecification especially with respect to random effects models in a range of situations. The pcVPC was in contrast to traditional VPCs shown to be readily applicable to data from studies with a priori and/or a posteriori dose adaptations.

Citing Articles

Multidose Dalbavancin Population Pharmacokinetic Analysis for Prolonged Target Attainment in Patients Requiring Long-Term Treatment.

Baiardi G, Cameran Caviglia M, Boni S, Di Paolo A, Marini V, Cangemi G Antibiotics (Basel). 2025; 14(2).

PMID: 40001433 PMC: 11852064. DOI: 10.3390/antibiotics14020190.


Integrating early response biomarkers in pharmacokinetic models: A novel method to individualize the initial infliximab dose in patients with Crohn's disease.

Samuels A, Irie K, Mizuno T, Reifenberg J, Punt N, Vinks A Clin Transl Sci. 2025; 18(2):e70086.

PMID: 39985779 PMC: 11846607. DOI: 10.1111/cts.70086.


Palbociclib exposure in relation to efficacy and toxicity in patients with advanced breast cancer.

Buijs S, Mohmaed Ali M, Oomen-de Hoop E, Braal C, Wortelboer N, van Ommen-Nijhof A ESMO Open. 2025; 10(3):104290.

PMID: 39954390 PMC: 11872518. DOI: 10.1016/j.esmoop.2025.104290.


Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug Olaparib.

Overbeek J, van Erp N, Burger D, den Broeder A, Koolen S, Huitema A Clin Pharmacokinet. 2025; .

PMID: 39909979 DOI: 10.1007/s40262-025-01480-w.


Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients.

Wang J, Fang Q, Luo X, Jin L, Zhu H Front Pharmacol. 2025; 15:1524272.

PMID: 39850576 PMC: 11754279. DOI: 10.3389/fphar.2024.1524272.


References
1.
Post T, Freijer J, Ploeger B, Danhof M . Extensions to the visual predictive check to facilitate model performance evaluation. J Pharmacokinet Pharmacodyn. 2008; 35(2):185-202. PMC: 2798054. DOI: 10.1007/s10928-007-9081-1. View

2.
Orloff J, Douglas F, Pinheiro J, Levinson S, Branson M, Chaturvedi P . The future of drug development: advancing clinical trial design. Nat Rev Drug Discov. 2009; 8(12):949-57. DOI: 10.1038/nrd3025. View

3.
Brynne L, MCNAY J, Schaefer H, Swedberg K, Wiltse C, Karlsson M . Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failure. Br J Clin Pharmacol. 2001; 51(1):35-43. PMC: 2014427. DOI: 10.1046/j.1365-2125.2001.01320.x. View

4.
Friberg L, de Greef R, Kerbusch T, Karlsson M . Modeling and simulation of the time course of asenapine exposure response and dropout patterns in acute schizophrenia. Clin Pharmacol Ther. 2009; 86(1):84-91. DOI: 10.1038/clpt.2009.44. View

5.
Bergstrand M, Hooker A, Wallin J, Karlsson M . Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J. 2011; 13(2):143-51. PMC: 3085712. DOI: 10.1208/s12248-011-9255-z. View